Pharma Focus Europe


The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

Singleron Unveils AccuraSCOPE® Single-Cell Transcriptome Technology

Wednesday, January 31, 2024

Singleron Biotechnologies a leading player in singlecell multiomic solutions for precision medicine has introduced two innovative products the AccuraSCOPE Single Cell Transcriptome and Genome Library Kit and the AccuraSCOPE Single Cell FullLength Tra...

Collaborative Effort for Advanced Cancer Therapies: Qubit Pharma, Institut Curie, and University of Bordeaux

Wednesday, January 31, 2024

Qubit Pharmaceuticals a deeptech company specializing in drug discovery through AI and simulation accelerated by hybrid HPC and quantum computing is collaborating with Institut Curie Frances leading cancer research center

Oxford Biomedica Successfully Concludes Acquisition of ABL Europe

Tuesday, January 30, 2024

Oxford Biomedica plc has successfully completed the acquisition of ABL Europe SAS from Institut Mrieux SA solidifying its standing as a leading cell and gene therapy Contract Development and Manufacturing Organization

Vergent Bioscience Reveals Phase 2 Findings Indicating VGT-309's Ability to Visualize Lung Tumors During Surgery

Monday, January 29, 2024

Vergent Bioscience recently shared new findings at the th Annual Meeting of The Society of Thoracic Surgeons The data reveal that VGT their investigational tumortargeted fluorescent imaging agent

Orchard Therapeutics Enters Agreement with Beneluxa Consortium to Facilitate Reimbursed Access to Libmeldy

Friday, January 26, 2024

Orchard Therapeutics a prominent global gene therapy company has recently announced a new agreement with the Beneluxa Initiative on Pharmaceutical Policy This agreement aims to facilitate reimbursed access to Libmeldy

Biomunex Pharmaceuticals commences Phase 1 Clinical Trial for its pioneering Bispecific Antibody designed for Cancer Treatment

Thursday, January 25, 2024

Biomunex Pharmaceuticals a prominent French biopharmaceutical company specializing in advanced immunotherapy development through bi and multispecific antibodies from its BiXAb platform has announced the initiation of a Phase clinical trial

Elegen and GSK Have Entered Into a Collaborative Licensing Agreement to Further Advance the Development of Elegen's Technology for Cell-free DNA Production

Thursday, January 25, 2024

Elegen a leader in DNA manufacturing innovation has announced a collaboration and licensing agreement with GSK The partnership aims to utilize Elegens proprietary technology for the production of cellfree DNA

GenEdit, Genentech Collaborate on Nanoparticles for Autoimmune Genetic Medicines

Wednesday, January 24, 2024

GenEdit Inc a developer of genetic medicines using its NanoGalaxy platform for precise tissue delivery has recently entered into a multiyear collaboration and license agreement with Genentech a member of the Roche Group

Oncodesign Services Acquires ZoBio, Strengthening Expertise in Small Molecule Drug Discovery

Wednesday, January 24, 2024

Oncodesign Services a leading Contract Research Organization specializing in drug discovery and preclinical services is expanding globally through the acquisition of ZoBio a Dutch Contract Research Organization

Vivtex and Astellas Pharma Announce a Collaborative Research Partnership

Wednesday, January 24, 2024

Vivtex Corporation a biotech company focused on advancing oral biologic therapies for major diseases has recently initiated a research collaboration with Astellas Pharma Inc a global pharmaceutical company The collaboration aims to assess Vivtexs pro...